In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061
Open Access
- 1 April 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (17), 17508-17514
- https://doi.org/10.1074/jbc.m313020200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimizationBioorganic & Medicinal Chemistry Letters, 2004
- 972 VX-950: the discovery of an inhibitor of the hepatitis C NS3·4A protease and a potential hepatitis C virus therapeuticHepatology, 2003
- Resistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine InhibitorAntimicrobial Agents and Chemotherapy, 2003
- Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA PanelClinical Infectious Diseases, 2003
- Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus InfectionAngewandte Chemie International Edition, 2003
- In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide InhibitorJournal of Virology, 2003
- Mutations in Hepatitis C Virus RNAs Conferring Cell Culture AdaptationJournal of Virology, 2001
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998